Update – MHRA Class 4 Medicines Defect Notification: Azithromycin 250 mg Capsules (Jubilant Pharmaceuticals NV)
This recall notification has been updated since its initial publication on 11 March 2025 to include the correct information in relation to the safety updates in the Patient Information Leaflet (PIL) and the changes that have been made in line with reference product PIL. MHRA Class 4 Medicines Notification: Azithromycin 250 mg Capsules (Jubilant Pharmaceuticals [...]
The post Update – MHRA Class 4 Medicines Defect Notification: Azithromycin 250 mg Capsules (Jubilant Pharmaceuticals NV) appeared first on Community Pharmacy England.
Recent Comments